Re-assessing the enhanced permeability and retention effect in peripheral arterial disease using radiolabeled long circulating nanoparticles

Biomaterials

Volumn 100, Issue , 2016, Pages 101-109

  England, Christopher G ^a   Im, Hyung Jun ^b,c   Feng, Liangzhu ^d   Chen, Feng ^b   Graves, Stephen A ^a   Hernandez, Reinier ^a   Orbay, Hakan ^e   Xu, Cheng ^b   Cho, Steve Y ^b   Nickles, Robert J ^a   Liu, Zhuang ^d   Lee, Dong Soo ^c   Cai, Weibo ^a,b,f  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c Seoul National University   (South Korea)

^d SOOCHOW UNIVERSITY   (China)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF WISCONSIN   (United States)

Author keywords

Enhanced permeability and retention (EPR) effect; Hindlimb ischemia; Iron oxide nanoparticle (IONP); Photoacoustic imaging; Positron emission tomography (PET); Reduced graphene oxide (RGO)

Indexed keywords

BLOOD; DOPPLER EFFECT; GRAPHENE; IRON OXIDES; METAL NANOPARTICLES; NANOPARTICLES; PHOTOACOUSTIC EFFECT; POSITRONS; SURGERY; TISSUE;

ENHANCED PERMEABILITY AND RETENTION EFFECTS; HIND LIMBS; IRON OXIDE NANOPARTICLE; PHOTO-ACOUSTIC IMAGING; POSITRON EMISSION TOMOGRAPHY (PET); REDUCED GRAPHENE OXIDES (RGO);

POSITRON EMISSION TOMOGRAPHY;

PEGYLATED REDUCED GRAPHENE OXIDE IRON OXIDE NANOPARTICLE CU 64; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE; UNCLASSIFIED DRUG; COPPER; FERRIC ION; FERRIC OXIDE; GRAPHITE; NANOPARTICLE;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; DRUG ACCUMULATION; EX VIVO STUDY; HISTOLOGY; ISOTOPE LABELING; LASER DOPPLER FLOWMETRY; LIMB ISCHEMIA; LIMB PERFUSION; MOUSE; MULTIMODAL IMAGING; NONHUMAN; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PHOTOACOUSTICS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOACTIVITY; ANIMAL; BAGG ALBINO MOUSE; CAPILLARY PERMEABILITY; CHEMISTRY; DIAGNOSTIC IMAGING; FEMALE; HINDLIMB; ISCHEMIA; PERMEABILITY; PROCEDURES; VASCULARIZATION;

ANIMALS; CAPILLARY PERMEABILITY; COPPER RADIOISOTOPES; FEMALE; FERRIC COMPOUNDS; GRAPHITE; HINDLIMB; ISCHEMIA; MICE, INBRED BALB C; NANOPARTICLES; PERIPHERAL ARTERIAL DISEASE; PERMEABILITY; PHOTOACOUSTIC TECHNIQUES; POSITRON-EMISSION TOMOGRAPHY;

EID: 84973445000     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2016.05.018     Document Type: Article

References (37)

1. Yang K., Feng L., Hong H., Cai W., Liu Z. Preparation and functionalization of graphene nanocomposites for biomedical applications. Nat. Protoc. 2013, 8:2392-2403.
2. Hong H., Zhang Y., Engle J.W., Nayak T.R., Theuer C.P., Nickles R.J., et al. In vivo targeting and positron emission tomography imaging of tumor vasculature with (66)Ga-labeled nano-graphene. Biomaterials 2012, 33:4147-4156.
3. Abdulhannan P., Russell D.A., Homer-Vanniasinkam S. Peripheral arterial disease: a literature review. Br. Med. Bull. 2012, 104:21-39.
4. Samolsky Dekel B.G., Melotti R.M., Gargiulo M., Freyrie A., Stella A., Di Nino G. Pain management in peripheral arterial obstructive disease: oral slow-release oxycodone versus epidural l-bupivacaine. Eur. J. Vasc. Endovasc. Surg. 2010, 39:774-778.
5. A. American Diabetes Peripheral arterial disease in people with diabetes. Diabetes Care 2003, 26:3333-3341.
6. Luscher T.F., Creager M.A., Beckman J.A., Cosentino F. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part II. Circulation 2003, 108:1655-1661.
7. Varu V.N., Hogg M.E., Kibbe M.R. Critical limb ischemia. J. Vasc. Surg. 2010, 51:230-241.
8. Berger J.S., Hiatt W.R. Medical therapy in peripheral artery disease. Circulation 2012, 126:491-500.
9. Tongers J., Roncalli J.G., Losordo D.W. Therapeutic angiogenesis for critical limb ischemia: microvascular therapies coming of age. Circulation 2008, 118:9-16.
10. Amsden B.G. Delivery approaches for angiogenic growth factors in the treatment of ischemic conditions. Expert Opin. Drug Deliv. 2011, 8:873-890.
11. Tu C., Das S., Baker A.B., Zoldan J., Suggs L.J. Nanoscale strategies: treatment for peripheral vascular disease and critical limb ischemia. ACS Nano 2015, 9:3436-3452.
12. Pollak A.W., Norton P.T., Kramer C.M. Multimodality imaging of lower extremity peripheral arterial disease: current role and future directions. Circ. Cardiovasc. Imaging 2012, 5:797-807.
13. Owen A.R., Roditi G.H. Peripheral arterial disease: the evolving role of non-invasive imaging. Postgrad. Med. J. 2011, 87:189-198.
14. Josephs S.C., Rowley H.A., Rubin G.D., G. American Heart Association Writing Atherosclerotic peripheral vascular disease symposium II: vascular magnetic resonance and computed tomographic imaging. Circulation 2008, 118:2837-2844.
15. Kim J., Cao L., Shvartsman D., Silva E.A., Mooney D.J. Targeted delivery of nanoparticles to ischemic muscle for imaging and therapeutic angiogenesis. Nano Lett. 2011, 11:694-700.
16. Zhang J., Wang G., Mao D., Han A.T., Xiao N.N., Qi X., et al. Targeted in vivo imaging of mouse hindlimb ischemia using fluorescent gelatin nanoparticles. J. Nanomater. 2015, 2015:7.
17. Stacy M.R., Zhou W., Sinusas A.J. Radiotracer imaging of peripheral vascular disease. J. Nucl. Med. 2013, 54:2104-2110.
18. Lee T.K., Hwang H., Na K.S., Kwon J., Jeong H.S., Oh P., et al. Effect of angiogenesis induced by consecutive intramuscular injections of vascular endothelial growth factor in a hindlimb ischemic mouse model. Nucl. Med. Mol. Imaging 2014, 48:225-229.
19. Kobayashi H., Watanabe R., Choyke P.L. Improving conventional enhanced permeability and retention (epr) effects; what is the appropriate target?. Theranostics 2013, 4:81-89.
20. Niiyama H., Huang N.F., Rollins M.D., Cooke J.P. Murine model of hindlimb ischemia. J. Vis. Exp. 2009, 1035.
21. Yang K., Hu L., Ma X., Ye S., Cheng L., Shi X., et al. Multimodal imaging guided photothermal therapy using functionalized graphene nanosheets anchored with magnetic nanoparticles. Adv. Mater. 2012, 24:1868-1872.
22. Orbay H., Hong H., Zhang Y., Cai W. Pet/spect imaging of hindlimb ischemia: focusing on angiogenesis and blood flow. Angiogenesis 2013, 16:279-287.
23. Shi S., Orbay H., Yang Y., Graves S.A., Nayak T.R., Hong H., et al. Pet imaging of abdominal aortic aneurysm with 64cu-labeled anti-cd105 antibody fab fragment. J. Nucl. Med. 2015, 56:927-932.
24. Yang Y., Hernandez R., Rao J., Yin L., Qu Y., Wu J., et al. Targeting cd146 with a 64cu-labeled antibody enables in vivo immunopet imaging of high-grade gliomas. Proc. Natl. Acad. Sci. U. S. A. 2015, 112:E6525-E6534.
25. Yang Y.Q., Asiri A.M., Tang Z.W., Du D., Lin Y.H. Graphene based materials for biomedical applications. Mater. Today 2013, 16:365-373.
26. Orbay H., Zhang Y., Hong H., Hacker T.A., Valdovinos H.F., Zagzebski J.A., et al. Positron emission tomography imaging of angiogenesis in a murine hindlimb ischemia model with 64cu-labeled trc105. Mol. Pharm. 2013, 10:2749-2756.
27. Lee C.W., Stabile E., Kinnaird T., Shou M., Devaney J.M., Epstein S.E., et al. Temporal patterns of gene expression after acute hindlimb ischemia in mice: insights into the genomic program for collateral vessel development. J. Am. Coll. Cardiol. 2004, 43:474-482.
28. Greish K. Enhanced permeability and retention (epr) effect for anticancer nanomedicine drug targeting. Methods Mol. Biol. 2010, 624:25-37.
29. Slovut D.P., Lipsitz E.C. Surgical technique and peripheral artery disease. Circulation 2012, 126:1127-1138.
30. Willmann J.K., Chen K., Wang H., Paulmurugan R., Rollins M., Cai W., et al. Monitoring of the biological response to murine hindlimb ischemia with 64cu-labeled vascular endothelial growth factor-121 positron emission tomography. Circulation 2008, 117:915-922.
31. Zhu M.T., Feng W.Y., Wang Y., Wang B., Wang M., Ouyang H., et al. Particokinetics and extrapulmonary translocation of intratracheally instilled ferric oxide nanoparticles in rats and the potential health risk assessment. Toxicol. Sci. 2009, 107:342-351.
32. Yashchenok A.M., Jose J., Trochet P., Sukhorukov G.B., Gorin D.A. Multifunctional polyelectrolyte microcapsules as a contrast agent for photoacoustic imaging in blood. J. Biophot. 2016, n/a-n/a. [Epub ahead of print].
33. Langhout G.C., Grootendorst D.J., Nieweg O.E., Wouters M.W., van der Hage J.A., Jose J., et al. Detection of melanoma metastases in resected human lymph nodes by noninvasive multispectral photoacoustic imaging. Int. J. Biomed. Imaging 2014, 2014:163652.
34. Abou D.S., Ku T., Smith-Jones P.M. In vivo biodistribution and accumulation of 89zr in mice. Nucl. Med. Biol. 2011, 38:675-681.
35. Schlorf T., Meincke M., Kossel E., Gluer C.C., Jansen O., Mentlein R. Biological properties of iron oxide nanoparticles for cellular and molecular magnetic resonance imaging. Int. J. Mol. Sci. 2010, 12:12-23.
36. Nagahama R., Matoba T., Nakano K., Kim-Mitsuyama S., Sunagawa K., Egashira K. Nanoparticle-mediated delivery of pioglitazone enhances therapeutic neovascularization in a murine model of hindlimb ischemia. Arterioscler. Thromb. Vasc. Biol. 2012, 32:2427-2434.
37. Cho B.R., Ryu D.R., Lee K.S., Lee D.K., Bae S., Kang D.G., et al. P-hydroxybenzyl alcohol-containing biodegradable nanoparticle improves functional blood flow through angiogenesis in a mouse model of hindlimb ischemia. Biomaterials 2015, 53:679-687.